Uranovia Cream (Eflornithine) for Unwanted Facial Hair
Uranovia Cream is a prescription topical cream from SKNV containing Eflornithine 13.9%. It is designed to help slow the rate of unwanted facial-hair regrowth in women; it does not remove existing hair. For dermatology providers, discussing Uranovia begins with the patient’s concerns, an appropriate clinical assessment, and clear expectations about how it may fit alongside existing hair removal practices. SKNV product information
How can providers discuss
unwanted facial hair with patients?
A neutral, open-ended question can help patients raise concerns they may not have previously discussed during a dermatology visit.
For example: “Are there any changes in facial hair or parts of your hair removal routine you would like to discuss?”
A patient may already have an established routine without knowing whether other management options are available. Ask what she has noticed, which methods she currently uses, and what she would like help addressing.
Choosing whether to address unwanted facial hair is personal. The discussion should reflect the patient’s priorities without assuming that every patient wants treatment.
When does unwanted facial hair warrant further evaluation?
The patient’s history and clinical presentation should guide whether further evaluation is appropriate. Unwanted facial hair alone does not establish an underlying diagnosis.
The Endocrine Society’s guidance on hirsutism in premenopausal women distinguishes localized unwanted hair growth from presentations that warrant endocrine testing. A topical prescription should sit within an appropriate clinical assessment and does not replace that evaluation. Endocrine Society guideline
For patients, it can be helpful to explain that evaluating a change in hair growth and discussing options to manage regrowth are related but separate parts of care.
How does Eflornithine affect facial hair growth?
Eflornithine acts on a substance within the hair follicle that is needed for hair growth, helping to slow the rate of new hair growth. MedlinePlus Eflornithine information
This ingredient-level information helps explain the treatment concept. It should not be presented as evidence of a specific clinical outcome for Uranovia Cream or as product-specific clinical trial evidence.
Does Uranovia Cream remove existing facial hair?
No. Uranovia Cream is not a depilatory and does not remove existing hair. It is designed to help slow the rate of regrowth over time.
Explain this distinction early, so patients understand how the prescribed medication may fit alongside their current hair removal practices. Discuss the role of each part of the plan without promising permanent hair removal or a particular treatment response.
Avoid guaranteeing a response or a fixed time for improvement. At follow-up, discuss the patient’s experience of regrowth, her ongoing hair removal routine, tolerability, and whether she has been able to follow the prescribed plan.
These observations can support a shared discussion about continuing or adjusting management.
What expectations should providers discuss before prescribing?
Set individualized goals and a follow-up plan before treatment begins. Patients should understand how to use the prescribed formulation, what to monitor, and whom to contact with questions.
A practical counseling checklist includes:
- Patient priorities: What does the patient hope to address?
- Current routine: Which hair removal methods does she use, and how might the prescription fit into that routine?
- Prescription directions: Does she understand the amount, frequency, and other instructions on her prescription label?
- Treatment expectations: Does she understand that slowing regrowth is different from removing existing hair?
- Tolerability: Which reactions should she report, and how should she contact the practice?
- Follow-up: When will the practice reassess her experience and the management plan?
What safety considerations should providers review?
Before prescribing, review allergies, medications and supplements, relevant skin concerns, and pregnancy or breastfeeding status. Counseling should address the specific formulation and the individual patient.
General Eflornithine information describes local adverse effects that may include burning, stinging, redness, rash, and acne. Counsel patients to report persistent or worsening reactions. Severe skin irritation requires stopping use and contacting the provider promptly. MedlinePlus Eflornithine information
This is not a complete list of precautions or possible adverse effects. General information about Eflornithine does not replace a review of the prescribed medication’s ingredients, directions, and precautions.
How can practices prescribe and order Uranovia Cream?
Your SKNV Consultant can provide Uranovia Cream product information and explain the applicable prescribing and ordering process. Uranovia Cream is listed as SKU 131102.
Depending on the practice’s program, access may include:
- In-office dispensing: Medication dispensed through the practice’s program, where available and appropriate.
- Direct-to-patient fulfillment: Medication fulfilled through SKNV Pharmacy.
Confirm the applicable process with your SKNV Consultant. When Uranovia Cream is prescribed, explain how the patient will receive the medication and whom to contact with questions.
For additional details, visit the Uranovia Cream product page.
Contact your SKNV Consultant to learn more about Uranovia Cream and its availability for your practice.
Important medication information
Uranovia Cream is made by SKNV LLC, an FDA-Registered 503B Outsourcing Facility. Medications made by such facilities are exempt from FDA review for safety, efficacy, or intended use, and do not require pre-approval clinical trials under the Federal Food, Drug, and Cosmetic Act. Any information provided here about any active ingredients is general in nature and not specific to any of SKNV’s medications. Federal law exempts outsourced medications, including their active ingredients, from clinical trials.
References
- Endocrine Society. Evaluation and Treatment of Hirsutism in Premenopausal Women: Clinical Practice Guideline Resources.
- MedlinePlus. Eflornithine drug information.
The clinical references provide general evaluation and ingredient information. They are not clinical studies of Uranovia Cream.